BL Corp
KOSDAQ:142760
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
BL Corp
Change in Working Capital
BL Corp
Change in Working Capital Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Change in Working Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
BL Corp
KOSDAQ:142760
|
Change in Working Capital
-₩3.6B
|
CAGR 3-Years
30%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
Celltrion Inc
KRX:068270
|
Change in Working Capital
-₩938.8B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-13%
|
|
|
O
|
OliX Pharmaceuticals Inc
KOSDAQ:226950
|
Change in Working Capital
₩7.2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Change in Working Capital
₩3.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Change in Working Capital
-₩6.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Change in Working Capital
-₩9.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
BL Corp
Glance View
BL Corp. engages in the development of biopharmaceutical products. The company is headquartered in Yongin, Gyeonggi-Do. The company went IPO on 2014-11-26. The firm is engaged in the manufacture and sale of health functional foods and functional cosmetics. In addition, the Company is engaged in the distribution of pharmaceuticals and medical supplies. The firm is engaged in the distribution of Glu 100 Tablets, CellribonQ, and GentaQ and other medicine to general hospitals and pharmacies.
See Also
What is BL Corp's Change in Working Capital?
Change in Working Capital
-3.6B
KRW
Based on the financial report for Sep 30, 2025, BL Corp's Change in Working Capital amounts to -3.6B KRW.
What is BL Corp's Change in Working Capital growth rate?
Change in Working Capital CAGR 5Y
17%
The average annual Change in Working Capital growth rates for BL Corp have been 30% over the past three years , 17% over the past five years .
